|
|
Article: Curemark Announces Senior Executive Promotions.
- Article from:
- Biotech Week
- Article date:
- October 21, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced the promotions of two senior executives. Dr. Elisa Zinberg has been appointed senior vice president of operations, and Matthew Heil, Ph.D., senior vice president of drug development. Both were vice presidents of the company (see also Drug Development).
Zinberg oversees day-to-day management of Curemark and is responsible for the implementation of the company's strategic plan and clinical program. Prior to joining Curemark in 2008, she was chief operating officer of The Masters Circle, LLC, a practice management and leadership development company, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Michael J. Fox Foundation and New York Academy of ...
Business Wire;
August 21, 2007 ;
700+ words
...NEW YORK -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The New York Academy of Sciences will co-host the inaugural ... Therapeutics Conference on Thursday, October 25, in New York City. This meeting is the first and only ...
|
|